These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35906074)

  • 1. Successful treatment of severe pityriasis rubra pilaris with secukinumab in a 3-year-old boy.
    Xu YH; Dong DD; Lin YF; Wang Q; Huang LM; Shi JQ
    Clin Exp Dermatol; 2022 Nov; 47(11):2043-2045. PubMed ID: 35906074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review.
    Liang JY; Ye RX; Tian X; Zhang SQ; Zhang XB
    Dermatol Ther; 2020 Nov; 33(6):e14097. PubMed ID: 32725719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.
    Boudreaux BW; Pincelli TP; Bhullar PK; Patel MH; Brumfiel CM; Li X; Heckman MG; Pittelkow MR; Mangold AR; Sluzevich JC
    Br J Dermatol; 2022 Nov; 187(5):650-658. PubMed ID: 35701384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
    Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
    Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
    Wassef C; Lombardi A; Rao BK
    Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.
    Hanfstingl K; Pekar-Lukacs A; Motz R; Guenova E; Hoetzenecker W
    Case Rep Dermatol; 2018; 10(2):97-100. PubMed ID: 29867429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pityriasis rubra pilaris].
    Quenan S; Laffitte E
    Ann Dermatol Venereol; 2018 Jan; 145(1):50-59. PubMed ID: 29290415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.
    Katharina M; Sylvia S; Matthias B; Ulrich M; Martin L
    Pediatr Dermatol; 2022 Jul; 39(4):659-661. PubMed ID: 35859269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept.
    Guedes R; Leite L
    Dermatol Ther; 2011; 24(2):285-6. PubMed ID: 21410618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis rubra pilaris as a systemic disease.
    Kamarachev J; Grozdev I; Darlenski R; Tsankov N
    Clin Dermatol; 2019; 37(6):657-662. PubMed ID: 31864444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical pityriasis rubra pilaris associated with arthropathy and osteoporosis: a case report with 15-year follow-up.
    Behr FD; Bangert JL; Hansen RC
    Pediatr Dermatol; 2002; 19(1):46-51. PubMed ID: 11860571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secukinumab emerges as a rapidly effective therapy for pityriasis rubra pilaris.
    Bonomo L; Levitt JO
    Cutis; 2018 May; 101(5):367-369. PubMed ID: 29894526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumscribed Juvenile Pityriasis Rubra Pilaris (Type 4) Koebnerising after a Hot Water Burn: Mild Disease with Maximum Koebner Response.
    Acar EM; Has S; Kilitci A; Kemeriz F
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):47-49. PubMed ID: 31032794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute juvenile pityriasis rubra pilaris in a 2-year-old child].
    Thölke A; Feller G; Schadendorf D; Goerdt S
    J Dtsch Dermatol Ges; 2004 May; 2(5):357-9. PubMed ID: 16281525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult onset pityriasis rubra pilaris.
    Sehgal VN; Srivastava G; Dogra S
    Indian J Dermatol Venereol Leprol; 2008; 74(4):311-21. PubMed ID: 18797049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pityriasis rubra pilaris].
    Artik S; Kuhn A; Neumann NJ; Ruzicka T; Megahed M
    Hautarzt; 2004 Oct; 55(10):980-3. PubMed ID: 15365642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic Pityriasis Rubra Pilaris Preceding Leukemia.
    Vance P; Wyles S; Alavi A
    Adv Skin Wound Care; 2022 Jun; 35(6):1-4. PubMed ID: 35703855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
    Di Stefani A; Galluzzo M; Talamonti M; Chiricozzi A; Costanzo A; Chimenti S
    J Dermatol Case Rep; 2013 Mar; 7(1):5-9. PubMed ID: 23580907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.